Target intelligence / Profile preview

Cyclin-dependent kinases regulatory subunit 2 (CKS2)

Target
CKS2
Molecular classification
Other (CDK regulatory subunit), Cell cycle protein
01

Overview

Cyclin-dependent kinases regulatory subunit 2 (CKS2) is a protein that binds and regulates the activity of cyclin-dependent kinases (CDKs), enzymes essential for cell cycle progression and division[4]. CKS2 is crucial for proper mitosis, specifically acting with CDK1-cyclin B to drive the G2/M transition and with CDK2 to modulate DNA replication under stress[1]. In cancer, CKS2 is often overexpressed, acts as an oncogene, and promotes cell proliferation, migration, and resistance to apoptosis[1]. Its dysregulation is associated with tumor progression and poor prognosis, making CKS2 a promising biomarker and a potential target for cancer molecular diagnostics and therapeutics[1][4].

Other names
CDC28 protein kinase regulatory subunit 2CKS2CKS-2CKSHS2CKS1 (S. cerevisiae Cdc28/Cdc2 kinase subunit) homolog-2Cyclin-dependent kinases regulatory subunit 2 (note: multiple minor spelling/capitalization variants are found in the literature)CDC28 protein kinase 2
02

Mechanism of action

CKS2 is not currently the primary molecular target of approved drugs; its mechanism is to regulate activity of cyclin-dependent kinases—drugs affecting CDKs may indirectly affect pathways involving CKS2

03

Biological functions

Cell cycle regulationSignal transductionCell proliferationCell divisionApoptosis regulation
04

Disease associations

CancerOther (implicated in cell proliferation and tumorigenesis)
05

Safety considerations

no direct drug safety concerns known, but targeting CKS2 may potentially interfere with normal cell cycle regulation in healthy dividing cells
06

Interacting drugs

no specific drugs are currently known to directly target CKS2; research focuses on its role in cancer signaling pathways rather than as a primary drug target
07

Biomarkers

CKS2 overexpression (biomarker for poor prognosis in multiple cancer types)

Beyond the preview

Go deeper on Cyclin-dependent kinases regulatory subunit 2 (CKS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyclin-dependent kinases regulatory subunit 2 (CKS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call